Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin

Glycyltyrosine API Manufacturers & Suppliers

1 verified results
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison

Commercial-scale Suppliers

Producer
Produced in  China
|

Employees: 450+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
CoA

All certificates

GMP
MSDS
BSE/TSE
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Get full market intelligence report
Get full market intelligence report
€399,-
All Glycyltyrosine data. Full access. Full negotiation power
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Glycyltyrosine | CAS No: 658-79-7 | GMP-certified suppliers

A medication that serves as an experimental dipeptide in peptide research, with potential applications in amino acid and protein-related therapeutic development.

Therapeutic categories

Amino Acids, Peptides, and ProteinsOligopeptidesPeptides
Generic name
Glycyltyrosine
Molecule type
small molecule
CAS number
658-79-7
DrugBank ID
DB15991
Approval status
Experimental drug

Product Snapshot

  • Glycyltyrosine is available as injectable solutions and emulsions intended for intravenous and parenteral administration
  • It is primarily utilized in investigational settings targeting metabolic and enzymatic modulation
  • This compound currently holds experimental status without formal approval from regulatory agencies

Clinical Overview

Glycyltyrosine (CAS number 658-79-7) is a dipeptide composed of the amino acids glycine and tyrosine. It is classified among amino acids, peptides, and proteins, specifically as an oligopeptide and peptide. Currently, glycyltyrosine remains in an experimental stage and has not been approved for clinical use or specific therapeutic indications.

As an experimental compound, detailed information about its pharmacodynamics and mechanism of action has not been established or publicly disclosed. Consequently, there is no defined clinical indication or pharmacological target associated with glycyltyrosine at this time.

Data on absorption, distribution, metabolism, and excretion (ADME) for glycyltyrosine are also not available. Given its peptide nature, it can be generally anticipated that glycyltyrosine may undergo enzymatic hydrolysis in biological systems, but definitive ADME profiles require confirmation through empirical studies.

Safety and toxicity profiles have not been characterized in the literature. The lack of comprehensive toxicological data precludes any conclusions regarding potential adverse effects, contraindications, or safety margins for glycyltyrosine.

No marketed pharmaceutical products or notable brand names incorporating glycyltyrosine are currently identified. Its usage remains primarily within research contexts aimed at exploring peptide functions or biochemical properties.

For sourcing and quality control of glycyltyrosine as an active pharmaceutical ingredient (API), it is essential to ensure compliance with established standards for peptide purity, identity, and stability. Proper documentation of manufacturing processes, along with batch-to-batch consistency verified through analytical methods such as HPLC and mass spectrometry, is critical to support experimental reproducibility and regulatory submissions. Suppliers should also provide certificates of analysis confirming the absence of contaminants and adherence to relevant pharmacopeial or research-grade specifications.

Identification & chemistry

Generic name Glycyltyrosine
Molecule type Small molecule
CAS 658-79-7
UNII A226496H4O
DrugBank ID DB15991

Formulation & handling

  • Glycyltyrosine is a small molecule suitable for intravenous or parenteral administration in solution or emulsion forms.
  • Its low LogP value (-2.6) and moderate water solubility support formulation in aqueous-based injectable preparations.
  • Handling should consider stability in solution, with attention to storage conditions to maintain formulation integrity.

Regulatory status

Glycyltyrosine is a type of Other substances


The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.

Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.

Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.

Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.

In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.

Glycyltyrosine API manufacturers & distributors

Compare qualified Glycyltyrosine API suppliers worldwide. We currently have 1 companies offering Glycyltyrosine API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Producer
China China BSE/TSE, CoA, GMP, MSDS15 products

When sending a request, specify which Glycyltyrosine API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Glycyltyrosine API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.